STOCK TITAN

Viatris Inc. to Release First Quarter 2021 Financial Results on May 10, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
earnings

PITTSBURGH, April 12, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) plans to release its first quarter 2021 financial results on Monday, May 10, before the open of the U.S. financial markets. The company also will host a webcast at 10 a.m. ET on May 10 to discuss the results.

Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 855.493.3607 or 346.354.0950 for international callers (ID#: 3557756).  A replay of the webcast also will be available on the website.

About Viatris 
Viatris Inc. (NASDAQ: VTRS) is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020 through the combination of Mylan and Pfizer's Upjohn business, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, a growing portfolio of biosimilars and a variety of over-the-counter consumer products. With a global workforce of approximately 45,000, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisIncLinkedIn and YouTube

Contacts:

Media:
+1.724.514.1968
Communications@viatris.com 

Jennifer Mauer
Head of Global Communications and Corporate Brand
Jennifer.Mauer@viatris.com

Investors:
+1.724.514.1813
InvestorRelations@viatris.com 

Bill Szablewski
Head of Capital Markets
William.Szablewski@viatris.com

Melissa Trombetta
Head of Investor Relations
Melissa.Trombetta@viatris.com

Viatris Logo (PRNewsfoto/Viatris Inc.)

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/viatris-inc-to-release-first-quarter-2021-financial-results-on-may-10-2021-301266422.html

SOURCE Viatris Inc.

Viatris Inc

NASDAQ:VTRS

VTRS Rankings

VTRS Latest News

VTRS Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Health Technology, Pharmaceuticals: Major

About VTRS

mylan is a global pharmaceutical company committed to setting new standards in healthcare. working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. we offer a growing portfolio of around 1,400 generic pharmaceuticals and several brand medications. in addition, we offer a wide range of antiretroviral therapies, upon which nearly 50% of hiv/aids patients in developing countries depend. we also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in about 145 countries and territories. our workforce of approximately 30,000 people is dedicated to creating better health for a better world, one person at a time. learn more at mylan.com.